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1. Introduction 
Crosslin~ng reagents are useful tools to stabilize 
purified proteins and to study their conformation and 
subunit assembly [l-3]. Yet their use to investigate 
protein organization in whole membranes inevitably 
leads to very complex data. A number of studies on 
erythrocyte membranes however suggest hat most 
crosslinked products must arise from long-term protein 
associations rather than from random interactions 
[4,5 ]. This encouraged us to apply crosslinking reagents 
to adenylate cyclase containing membranes in an 
attempt to study the association of the several com- 
ponents of the enzyme. In [6], we analyzed how the 
exposure of rat cerebellar synaptosomes to aldehydes 
affected adenylate cyclase activity and regulation. We 
showed that aldehydes induced a loss of enzyme regu- 
lation by some effecters (GTP, guanylylimidodiphos- 
phate (Gpp(NH)p), NaF and EGTA) but not by others 
(Ca2+, adenosine). We also showed that aldehydes 
maintained the preestablished activated state of the 
enzyme in the particulate and soluble forms. Here, we 
describe the effects on adenylate cyclase activity and 
regulation of the exposure of rat brain synaptosomes 
to the monofunction~ and bifunction~ imidoesters 
methylacetimidate and dimethylsube~midate (DMS). 
2. Materials and methods 
2.1. Preparation of synaptosomes 
Cerebellar synaptosomes were prepared as in [6]. 
For cerebral synaptosomes, the homogenate was 
adjusted to 27% refractive index. 
2.2. Treatment of synapt5s5mes 
The pellets of washed synaptosomes were resus- 
pended at S-10 mg protein/ml final cont. in cold 
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50 mM triethanolamine (TEA) buffer (pH 8.1) con- 
taining 10% sucrose (w/v) and 5 mM MgC12, and 
divided into aliquots. They were ~cubated for 30 min 
at 36°C without further addition (control synapto- 
somes) or with 20 mM NaF or 0.2 mM Gpp(NH)p 
(preincubated synaptosomes). Each sample was then 
divided into aliquots which were further treated with 
DMS or methylacetimidate or buffer, in the dark, for 
30 min at 4°C when the final pH was 8.1, or, in a few 
experiments, for 5 min at 20°C when the final pH was 
adjusted to 9 .O. The fractions were then diluted 6-fold 
with 50 mM TEA buffer (PH 8.1) and centrifuged at 
100 000 X g, 15 min, at 4°C. The pellets were resus- 
pended in the same buffer and used at once or kept 
frozen in liquid nitrogen. 
2.3. Solubilization of synaptosomes 
Synaptosomes were solubilized as in [6] with 
minor modifications. The 50mM TEA buffer (PH 8.1) 
contained 2 mM dithiothreitol (DTT), 1 mM EDTA, 
2 mM MgClz and 0.8% Lubrol-PX (Lubrol/protein ratio 
(w/w) 23). Homogenization was by hand in a Potter 
type-l homogenizer, using 40 strokes. The suspensions 
were centrifuged at 40 000 X g for 10 min. 
2.4. A~eny~ate cyclase assays 
They were performed as in [7]. Linearity of the 
reaction with time was checked in all instances. When 
the effect of Gpp(NH)p or NaF was studied in soluble 
fractions preincubation was performed at 22°C for 
3 5 h in the presence of either effector, or of GTP in 
the case of control samples. Aliquots were also prein- 
cubated at 4°C to ascertain that the observed changes 
were due to an activation rather than a protective effect 
of the effecters upon the enzyme. 
2 5. Source of mate~ls 
This was as in [6] except for [a-32P]ATP (2.5 Ci/ 
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mmol) which was from ICN. ~me~y~sub~rimidate 
and methyla~etimidate were from Sigma. 2’,5’-Dide- 
oxyadenosine was from ICN. 
3. Results 
3 .l . Effects of the monofunctional imidoester on the 
activity of membrane-bound adenylate cyciase 
Treatment of cerebral synaptosomes with increasing 
concentrations of me~yla~etimidate caused a progres- 
sive increase in particulate adenylate cyclase activity 
which reached 1 &fold the control value at 50 mM 
reagent (fig.1). The adenylate cyclase activity of sam- 
ples preincubated in Gpp(NH)p or NaF was however 
unaffected by the addition of methylacetimidate. The 
regulation of the enzyme was comparable in methyl- 
acetimidate-treated and untreated synaptosomes. 
Gpp(NH)p and NaF added to the assay stimulated 
>2-fold the enzyme activity (fig.2) except in the case 
of samples already preincubated with Gpp(NH)p or 
NaF, which no longer responded to further exposure 
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Fig.1. Aliquots of cerebral synaptosomes were incubated for 
30 min in TEA-MgCt,-sucrose buffer (see section 2), with- 
out addition (e,o), with 20 mM NaF (A), and with 0.2 mM 
Gpp(NH)p (m). The cooled samples were then treated with 
DMS (-) or methylacetimidate (---) at various concentra- 
tions (abscissa), and processed as in section 2. The resuspended 
pellets were assayed for adenylate cyclase activity at 36°C in 
the presence of 0.5 mM ATP and 5 mM MgCl,. 
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Fig.2. Aliquots of control cerebral synaptosomes were treated 
with increasing DMS concentrations (abscissa). The resus- 
pended fractions were then incubated at 36°C for 30 min in 
TEA buffer containing 5 mM MgCI,, without addition (basal 
activity), or in the presence of 10 mM NaF (0) or of 0.1 mM 
Gpp~NH)p (a), and assayed for adenylate cyclase. Ordinate: 
stimulation factor produced by each effector. (Basal activity 
taken for 1.) 
to either effector. Adenosine @lo0 PM) and its ana- 
logs, Ca*+ @50 uM) and EGTA (>lOO PM) inhibited 
adenylate cyclase in all cases, by a factor of 80%, 70% 
and 50%, respectively (fig.3). 
3.2. Effects of the bifunctiona~ imidoester on the 
activity of membrane-bound adenylate cyclase 
Treatment of control synaptosomes with increasing 
concentrations of DMS caused a progressive increase 
in particulate adenylate cyclase activity, reaching 1.6 
fold the value found in untreated samples at 25 mM 
reagent (fig.1). Above that concentration, the enzyme 
activity started to decline. The presence of the enzyme 
substrate, ATP, in the incubation medium did not 
affect the results. The adenylate cyclase of samples 
exposed to &20 mM DMS retained the capacity to be 
further stimulated by NaF or Gpp(NH)p (fig.2). How- 
ever, in samples treated with X mM DMS, this stim- 
ulatory effect decreased as a function of increasing 
bifunctional reagent concentration. The inhibitory 
effects of adenosine and its analogs, and of Ca2+ were 
unaffected by the preexposure of samples to DMS 
(fig.3). The inhibitory effect of EGTA was retained in 
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Fig.3. Aliquots of cerebral synaptosomes (NaF or Gpp(NH)p 
preactivated samples, or control samples) were treated with 
increasing DMS concentrations (abscissa). The resuspended 
fractions were preincubated for 3 min at 36°C without addi- 
tion (basal activity), or in the presence of 1 mM 2’deoxy- 
adenosine (n), 1 mM Ca’+ (A), or 1 mM EGTA (m), and then 
assayed for adenylate cyclase. 0rdinate:percent of the basal 
activity (taken for 100%). 
samples treated with up to 10 mM DMS, and progres- 
sively diminished in samples treated with higher DMS 
concentrations (fig.3). 
Synaptosomes preincubated in Gpp(NH)p or NaF 
were also treated with increasing concentrations of 
DMS. This resulted in an additional increase in partic- 
ulate adenylate cyclase activitywithrespect to synapto- 
somes pre-incubated in Gpp(NH)p or NaF but unex- 
posed to DMS (fig.1). The increase in enzyme activity 
paralleled the increase in crosslinking reagent.up to 
25 mM. Above that value, the enzyme activity 
decreased. In such samples preactivated by Gpp(NH)p 
or NaF, the adenylate cyclase could no longer be acti- 
vated by either effector. The effects of Ca*+, adenosine 
and EGTA were comparable to those found in samples 
preincubated in buffer only and treated with DMS. 
3.3. Properties of adenylate cyclase solubilized from 
imidoester-treated synaptosomes 
Imidoester-treated and untreated synaptosomes 
were solubilized with Lubrol-PX. As expected from 
[6], the total adenylate cyclase activities in the Lubrol- 
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Fig.4. Gpp(NH)p preactivated cerebral synaptosomes were 
treated with increasing DMS concentrations (abscissa). The 
resuspended fractions were solubilized by homogenization 
in Lubrol-PX and centrifuged (see section 2). The percentage 
of soluble versus total proteins (A--A) and of soluble versus 
total adenylate cyclase activity (a-m) are plotted in the 
ordinates. The curves obtained for control or NaF preactivated 
cerebral synaptosomes were similar. 
treated fractions were >3-fold higher than in the cor- 
responding particulate fractions. The percentage of 
solubilized proteins and of soluble versus total enzyme 
activity decreased with increasing DMS concentrations 
(fig.4) while exposure of synaptosomes up to 100 mM 
methylacetimidate did not affect the extent of enzyme 
solubilization. Whatever the history of the samples 
(control or preincubated with Gpp(NH)p or NaF), the 
soluble adenylate cyclase specific activities increased 
as a function of DMS up to 25 mM (table 1). 
In all fractions, the adenylate cyclase activity was 
stimulated by Gpp(NH)p, provided that a long pre- 
incubation time in the presence of the effector be 
allowed (see section 2). The extent of activation of 
the soluble enzyme depended upon the preincubation 
step and conditions of DMS treatment undergone by 
the synaptosomes (table 1). Adenylate cyclase solu- 
bilized from control synaptosomes not treated by 
DMS was stimulated 2.6-fold by Gpp(NH)p. The 
enzyme solubilized from control samples treated with 
DMS was also stimulated by Gpp(NH)p, the extent of 
activation decreasing as a function of increasing DMS 
concentration (table 1). In the case of synaptosomes 
(preincubated in NaF or Gpp(NH)p, although the par- 
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Table 1 
Effects of DMS treatment of synaptosomes on the regulation of the solubilized adenylate 
cyclase 
DMS 
(mM) 
Basal enzyme Gpp(NH)p NaF EGTA Ca2+ 2’,5’dideoxy 
(spec. act.) (0.1 mM) (10 mM) (0.1 mM) (1 mM) adenosine 
0 614 x 2.7 x 0.90 x 0.4 x 0.14 X 0.07 
5 740 x 2.2 X 0.96 X 0.55 x 0.14 X 0.07 
10 854 x 2.1 Xl X 0.60 x 0.14 X 0.06 
20 1082 x 2.1 Xl x 0.73 x 0.13 X 0.06 
50 1216 X 1.8 X 0.96 x 0.88 x 0.12 X 0.06 
Control cerebral synaptosomes were treated with various DMS concentrations, washed, and 
solubilized (see section 2). The soluble enzyme activities were measured at 30°C in the presence 
of 0.3 mM ATP. The samples were preincubated for 3.5 h at 22°C with 0.1 mM Gpp(NH)p or 
10 mM NaF, in the presence of 5 mM MgCl,, or 3 mm with 0.1 mM EGTA or 1 mM Ca’+, in the 
presence of 5 mM MgCl,, or 0.5 mM 2’,5’dideoxyadenosine in the presence of 5 mM MnCl,; 
the samples were then assayed for adenylate cyclase. The basal specific activities (in the presence 
of 5 mM MgCl,) are given in pmol CAMP . mg-’ mine’. Relative stimulations or inhibitions 
caused by incubation in the presence of various effecters are expressed as respect to the corre- 
sponding basal enzyme activities, taken for 1 for each sample 
ticulate enzyme could no longer be activated by Gpp- 
(NH)p, the enzyme prepared from such samples could 
still be stimulated 1.2-l .4-fold by Gpp(NH)p. In 
contrast with the Gpp(NH)p stimulation, activation 
of the soluble enzyme by NaF could not be demon- 
strated (table 1). 
In all tested fractions, the adenylate cyclase activ- 
ity was inhibited by adenosine and its analogs and 
Ca*+. (table 1). The extent of inhibition by EGTA of 
the soluble enzyme dependent upon the DMS concen- 
tration, exactly as in the case of the particulate 
enzyme (table 1). Enzyme solubilized from 50 mM 
DMS-treated samples was practically insensitive to 
EGTA. 
The apparent stability of the soluble adenylate 
cyclase activities were studied at 38’C (fig.5) and at 
28°C. The enzyme activity sharply declined after 
3 min incubation at 38°C and was no longer detected 
after 15-25 min in samples prepared from fractions 
incubated with or without methylacetimidate or DMS 
up to 10 mM (fig.5). On the contrary, the adenylate 
cyclase apparent inactivation was much slower in frac- 
tions solubilized from 50 mM DMS-treated samples. 
Two slopes were seen, the first one rather steep, during 
the first 10 min, the second very shallow, almost 
amounting to a plateau. Although the extent of appar- 
ent enzyme inactivation (measured at the plateau) 
somewhat varied from one experiment to the other, 
-50% of the enzyme activity of 50 mM DMS-treated 
samples was still present after 30 min incubation at 
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38°C whereas little activity was left in 20 mM DMS- 
treated samples, and none in untreated samples or 
samples treated with low DMS concentrations. The 
apparent adenylate cyclase stabilization observed in 
50 mM DMS-treated samples was further enhanced by 
preactivation of the samples by Gpp(NH)p, a proce- 
dure which however had hardly any effect on the 
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Fig.5. Gpp(NH)p preactivated cerebral synaptosomes were 
treated with buffer or 10 mM DMS (o-o), 20 mM DMS 
(=--=) or 50 mM DMS (A--A) and solubihzed (see sec- 
tion 2). The soluble enzyme activities (ordinate, nmol CAMP 
mg-’ mm-‘) were measured after various incubation times 
at 36”C, according to 171. 
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enzyme stability of samples treated with lower DMS located on the so-called N subunits 191. Cross- 
concentrations. Preincubation of the samples with linking agents might then affect the association 
NaF did not noticeably affect the enzyme apparent state of the catalytic and of the regulatory N sub- 
stability. Comparable results were observed at 28”C, units, or they might alter any one of the compo- 
the apparent inactivation of adenylate cyclase being nents. 
however much slower in all samples. The DMS treatment of synaptosomes produced 
4. Discussion 
Treatment of brain synaptosomes by the mono- 
functional imidoester methylacetimidate and by the 
bifunctional reagent dimethylsuberimidate DMS 
resulted in an increase in the particulate and the solu- 
bilized adenylate cyclase activities. A direct effect on 
enzyme activation of the imidination of some sites of 
adenylate cyclase is thus likely, but appears however 
insufficient o account for the increase observed in 
the enzyme activity of DMS-treated fractions. DMS 
was indeed able to increase the adenylate cyclase 
activity of fractions pre-stimulated with Gpp(NH)p 
and NaF, whereas methylacetimidate had no effect 
on such fractions. The regulation of adenylate cyclase 
was affected by DMS, but not methylacetimidate, 
treatment. 
intermolecular c osslinks, since there was a sharp 
decrease in the extent of protein, and of adenylate 
cyclase solubilization. Whether intermolecular c oss- 
links also form within the soluble adenylate cyclase 
entities is currently being studied. Preliminary data 
indicate that the apparent S values of enzymes olu- 
bilized from Gpp(NH)p or NaF preactivated. DMS- 
treated fractions are larger than those from corre- 
sponding samples not treated by DMS [lo]. The 
presence of physiolo~~~ly relevant molecules (such 
as regulatory subunits, or receptors) in the soluble 
complexes will be sought. 
Import~t sim~arities xist in the effects of alde- 
hydes and of DMS upon adenylate cyclase properties 
and regulation. In DMS-treated fractions, however, 
the enzyme basal activity was enhanced even at high 
crosslinking reagent concentrations, whereas treat- 
ment with 21 mM glutaraldehyde quickly led to 
enzyme inactivation [6]. Using rather low (GlO mM) 
DMS concentrations, it was also possible to obtain an 
adenylate cyclase with enhanced basal activity (as 
compared to the untreated enzyme), while still being 
susceptible to activation by NaF and Gpp(NH)p. In 
~dehyde-treated fractions, on the contrary, complete 
desensitization f the enzyme towards NaF and Gpp- 
(NH)p was seen at the lowest tested aldehyde concen- 
trations [6]. Yet the two categories of crosslinking 
agents allow the distinction of two classes of regula- 
tory sites within the adenylate cyclase complex: 
(i) Those which are unaffected by the crosslinking 
agents, Ca2+ site, adenosine site, presumably the 
P site [8], and may be closely related to the cata- 
lytic site; 
Intramolecular c osslinks have been implied in the 
enhancement of conformational stability, and used to 
prevent or retard denaturation [Ill. Since the frac- 
tion of 50 mM DMStreated adenylate cyclase which 
could be solubilized had gained increased apparent 
thermal stability, DMS may have been freezing the 
enzyme catalytic subunit in an active conformation, 
but however not in such a rigid way as to prevent he 
enzyme from being inhibited by Ca2+ and adenosine. 
Using a related compound, 3,3’-dithiobispropion- 
imidate, on a different system, an apparent stabiliza- 
tion of adenylate cyclase to dispersion in detergent 
was reported [12,131. Finally, the progressive loss of 
EGTA inhibition occuring upon aIdehyde or DMS 
treatment, presumably related to the permanent 
trapping of M.n2+ inside the complex, might be related 
to either inter- or intra-molecular Crosslinks. Purifica- 
tion of the crosslinked entities hould thus help to 
dissect he complex adenylate cyclase architecture. 
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(ii) Those which are affected by these agents and 
become functionally uncoupled from the catalytic 
site. Among those sites, two, the NaF site and 
the GTP site of action, are now known to be 
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